Idiopathic Pulmonary Fibrosis is Associated with Circulating Antiepithelial Antibodies
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00408-012-9390-z.pdf
Reference37 articles.
1. Lynch JP III, Wurfel M, Flaherty K, White E, Martinez F, Travis W, Raghu G (2001) Usual interstitial pneumonia. Semin Respir Crit Care Med 22(4):357–386
2. King TE Jr, Safrin S, Starko KM, Brown KK, Noble PW, Raghu G, Schwartz DA (2005) Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis. Chest 127(1):171–177
3. King TE Jr, Behr J, Brown KK, Du Bois RM, Lancaster L, de Andrade JA, Stahler G, Leconte I, Roux S, Raghu G (2008) BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 177(1):75–81
4. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE Jr (2004) A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 350(2):125–133
5. Raghu G, Brown KK, Costabel U, Cottin V, Du Bois RM, Lasky JA, Thomeer M, Utz JP, Khandker RK, McDermott L, Fatenejad S (2008) Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med 178(9):948–955
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intrapulmonary Autoantibodies to HSP72 Are Associated with Improved Outcomes in IPF;Journal of Immunology Research;2019-04-11
2. Antineutrophil Cytoplasmic Antibody–Associated Lung Fibrosis;Seminars in Respiratory and Critical Care Medicine;2018-08
3. Anti-parietal cell autoimmunity is associated with an accelerated decline of lung function in IPF patients;Respiratory Medicine;2018-02
4. Chemokine receptors and their therapeutic opportunities in diseased lung: Far beyond leukocyte trafficking;American Journal of Physiology-Lung Cellular and Molecular Physiology;2015-04-01
5. The epithelium in idiopathic pulmonary fibrosis: breaking the barrier;Frontiers in Pharmacology;2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3